Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation
Authors
Keywords
-
Journal
BMC Medical Genetics
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-01
DOI
10.1186/s12881-020-01173-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional rescue of an ABCB11 mutant by ivacaftor: a new targeted pharmacotherapy approach in bile salt export pump deficiency
- (2020) Elodie Mareux et al. LIVER INTERNATIONAL
- Liver-directed gene therapy results in long term correction of progressive familial intrahepatic cholestasis type 3 in mice
- (2019) Sem J. Aronson et al. JOURNAL OF HEPATOLOGY
- Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model
- (2019) Nicholas D. Weber et al. Nature Communications
- Progressive Familial Intrahepatic Cholestasis
- (2018) Laura N. Bull et al. Clinics in Liver Disease
- Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)
- (2016) Jean-Louis Delaunay et al. HEPATOLOGY
- Biliary atresia and other cholestatic childhood diseases: Advances and future challenges
- (2016) Henkjan J. Verkade et al. JOURNAL OF HEPATOLOGY
- Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3
- (2016) Hyo Jin Park et al. Scientific Reports
- Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones
- (2016) Raquel Gordo-Gilart et al. PLoS One
- Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate
- (2015) Emmanuel Gonzales et al. HEPATOLOGY
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Autoimmune BSEP Disease: Disease Recurrence After Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
- (2014) Ralf Kubitz et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Functional analysis ofABCB4mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity
- (2014) Raquel Gordo-Gilart et al. GUT
- The Genetics of Complex Cholestatic Disorders
- (2013) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Progressive Familial Intrahepatic Cholestasis Type 3
- (2012) Ramya Ramraj et al. CLINICAL PEDIATRICS
- Cholestatic Liver Diseases from Child to Adult: The Diversity of MDR3 Disease
- (2011) R. Kubitz et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Liver disease associated with canalicular transport defects: Current and future therapies
- (2009) Janneke M. Stapelbroek et al. JOURNAL OF HEPATOLOGY
- Progressive familial intrahepatic cholestasis
- (2009) Anne Davit-Spraul et al. Orphanet Journal of Rare Diseases
- Structural insights into ABC transporter mechanism
- (2008) Michael L Oldham et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now